--- title: LYVA Labs - IUK Biomedical Catalyst Future Medicines Accelerator description: LYVA Labs in partnership with Innovate UK launches the Innovate UK Biomedical Catalyst Accelerator Future Medicines. --- [![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/?hsLang=en) - About - [Our purpose](https://lyvalabs.com/about) - [Case studies](https://lyvalabs.com/case-studies) - [Team](https://lyvalabs.com/team) - [News](https://lyvalabs.com/news) - [Annual Report](https://lyvalabs.com/annualreport25-26) - [Investment](https://lyvalabs.com/investment-fund) - Programmes - [Adapt](https://lyvalabs.com/adapt) - [Incubator](https://lyvalabs.com/incubator) - [Accelerate](https://lyvalabs.com/accelerate) - Services - [Consortia](https://lyvalabs.com/consortia) - Work with Us - [Careers](https://lyvalabs.com/vacancies) - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities) [![logo](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo.svg "logo")](https://lyvalabs.com/?hsLang=en) - About - [Our purpose](https://lyvalabs.com/about) - [Case studies](https://lyvalabs.com/case-studies) - [Team](https://lyvalabs.com/team) - [News](https://lyvalabs.com/news) - [Annual Report](https://lyvalabs.com/annualreport25-26) - [Investment](https://lyvalabs.com/investment-fund) - Programmes - [Adapt](https://lyvalabs.com/adapt) - [Incubator](https://lyvalabs.com/incubator) - [Accelerate](https://lyvalabs.com/accelerate) - Services - [Consortia](https://lyvalabs.com/consortia) - Work with Us - [Careers](https://lyvalabs.com/vacancies) - [Consultants](https://lyvalabs.com/lyva-labs-expert-partner-opportunities) [Contact Us](https://lyvalabs.com/contact?hsLang=en) [Contact Us](https://lyvalabs.com/contact?hsLang=en) # Innovate UK Biomedical Catalyst Accelerator - Future Medicines ![Future Medicines Accelerator](https://lyvalabs.com/hubfs/Picture2.png "Future Medicines Accelerator") # This Competition is NOW CLOSED # The submission date was: 5pm Tuesday 30th September 2025 ![Innovate UK logo](https://lyvalabs.com/hubfs/Innovate%20UK%20logo.png "Innovate UK logo") ![](https://lyvalabs.com/hs-fs/hubfs/Afternoon%20Session%20-%20IUK%202.jpg?width=2000&height=1227&name=Afternoon%20Session%20-%20IUK%202.jpg) ### Overview LYVA Labs, in partnership with Innovate UK and a consortium of internationally recognised scientific, technical, and commercial experts, is proud to launch the **Innovate UK Biomedical Catalyst Accelerator - Future Medicines**. The Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism, designed to accelerate innovation and help UK companies bring products to market more efficiently. Part of the Innovate UK Biomedical Catalyst, Accelerators help SMEs, spinouts, and academic innovators develop and test innovative health and care solutions across therapeutics, medical devices, diagnostics, and digital health. Through thematic Accelerators, participants gain tailored support to refine their ideas, explore market viability, and prepare for clinical or commercial validation. ### Who is this for?   UK-based SMEs (as defined by Innovate UK).   Academics in the early stages of forming an SME   Start-ups developing innovations within the scope of *Future Medicines* addressing clear and evidenced healthcare challenges.   At early-stage Technology Readiness Levels typically [TRL2-4](https://www.ukri.org/councils/stfc/guidance-for-applicants/check-if-youre-eligible-for-funding/eligibility-of-technology-readiness-levels-trl/)  Companies with technologies, products, processes, or services that have a commercial route to market.  Organisations working in radiopharmaceuticals innovation particularly encouraged. ![](https://lyvalabs.com/hs-fs/hubfs/radiop.png?width=1800&height=1200&name=radiop.png) ### Sectors in-scope The development, discovery or manufacturing of a broad range of next-generation medical treatments, technologies, products, processes, or services to address increasingly complex diseases, usually leveraging advanced scientific approaches for more targeted, effective therapies tailored to individual patient needs. Update 12pm 26th September: We have now closed submissions for all sectors with the exception of radiopharmaceuticals. For companies working in radiopharmaceutical we have extended the deadline to 5pm Tuesday 30th September. This extension is for radiopharmaceutical companies only. New applications (after 12pm 26th September) only working in other future medicines sectors will not be assessed. ![](https://lyvalabs.com/hs-fs/hubfs/Launch%20post%20(4).png?width=200&height=200&name=Launch%20post%20(4).png) ###### Radiopharmaceuticals ![](https://lyvalabs.com/hs-fs/hubfs/Launch%20post%20(5).png?width=200&height=200&name=Launch%20post%20(5).png) ###### Microbiome and Phage-based therapies ![](https://lyvalabs.com/hs-fs/hubfs/biopharm.png?width=200&height=200&name=biopharm.png) ###### Biopharmaceuticals ![](https://lyvalabs.com/hs-fs/hubfs/regen%20meds.png?width=200&height=200&name=regen%20meds.png) ###### Regenerative and Personalised Medicines ![](https://lyvalabs.com/hs-fs/hubfs/cell%20therapy.png?width=200&height=200&name=cell%20therapy.png) ###### Gene therapies and CAR-T cell therapies ![](https://lyvalabs.com/hs-fs/hubfs/other%20future%20meds.png?width=200&height=200&name=other%20future%20meds.png) ###### Antimicrobial resistance ### Programme Structure **Pre-Accelerator (Nov 2025 – Dec 2025):** Companies will build a strong foundation in drug discovery, development, regulation, market strategy, and exploitation planning, with guidance on grants, early-stage financing, and investment readiness - while establishing a peer network. **Accelerator (Jan 2026 –Mar 2026):** A select group from the Pre-Accelerator will receive tailored technical, scientific, and commercial support, a detailed R&D and exploitation plan, support to draft grant applications, investor pitch training, sector-specific introductions, and a personalised pack to support future funding. ![Partner - CPI](https://lyvalabs.com/hs-fs/hubfs/Partner%20-%20CPI.jpg?width=2000&height=1325&name=Partner%20-%20CPI.jpg "Partner - CPI") ### What you receive on the Accelerator ![Afternoon Session 3](https://lyvalabs.com/hs-fs/hubfs/Afternoon%20Session%203.jpg?width=2000&height=1283&name=Afternoon%20Session%203.jpg "Afternoon Session 3") - World-leading expertise in drug discovery, development, and regulation - Market research, competitive analysis, and commercial strategy support - Investment readiness training, pitch preparation, and funding guidance - Support to draft a grant application - Access to cutting-edge research facilities and networking with sector experts - The opportunity to work with partners to develop technical roadmaps - Face-to-face peer and investor events # About Innovate UK Innovate UK, part of UK Research and Innovation (UKRI), is the UK’s innovation agency. It works to create a better future by inspiring, involving and investing in businesses developing life-changing innovations. Its mission is to help companies to grow through their development and commercialisation of new products, processes and services, supported by an outstanding innovation ecosystem that is agile, inclusive and easy to navigate. **Innovate UK: inspiring business innovation.** [![Innovate UK Logo](https://lyvalabs.com/hs-fs/hubfs/Innovate%20UK%20Logo.jpg?width=400&height=266&name=Innovate%20UK%20Logo.jpg "Innovate UK Logo")](https://lyvalabs.com/?hsLang=en) ### Competition now closed. Any queries should be sent to [futuremedicines.accelerator@lyvalabs.com](mailto:futuremedicines.accelerator@lyvalabs.com)  We have now closed submissions for all sectors. For companies working in radiopharmaceuticals the extended deadline was 5pm Tuesday 30th September. [![logo-light](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/logo-light.svg "logo-light")](https://lyvalabs.com/?hsLang=en) - [![location](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/location.svg) Central Tech, 31 Russell St, Liverpool, L3 5LJ ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://maps.app.goo.gl/2UkwzwAXMeanwV4s9) - ![mail](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/mail.svg) enquiries@lyvalabs.com ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg) - [![linkedin](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/linkedin.svg) LinkedIn ![](https://lyvalabs.com/hubfs/LYVA_Labs_2026/Images/General/link.svg)](https://www.linkedin.com/company/lyvalabs/) About Us - [Our purpose](https://lyvalabs.com/about?hsLang=en) - [News](https://lyvalabs.com/news?hsLang=en) - [Case studies](https://lyvalabs.com/case-studies?hsLang=en) Programmes - [Incubator](https://lyvalabs.com/incubator?hsLang=en) - [Accelerate](https://lyvalabs.com/accelerate?hsLang=en) - [Adapt](https://lyvalabs.com/adapt-waitlist?hsLang=en) Services - [Investment](https://lyvalabs.com/investment-fund?hsLang=en) - [Consortia](https://lyvalabs.com/consortia?hsLang=en) Keep up to date with LYVA Labs by subscribing to our newsletter. © 2026 LCR Ventures trading as LYVA Labs. All rights reserved. - Terms & Conditions - [Privacy Policy](https://lyvalabs.com/privacy-policy?hsLang=en)